Loading clinical trials...

Treatment Protocol for Clofazamine in the Long Term Treatment of Leprosy | Clinical Trials | Clareo Health

No Longer AvailableNCT00852345

Treatment Protocol for Clofazamine in the Long Term Treatment of Leprosy

Clofazimine has shown effectiveness in the treatment of leprosy for many years. The World Health Organization and the National Hansen's Disease Program consider clofazamine to be standard therapy for ...

Lead sponsor: Kaiser Permanente•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGNA

Novel Interventions and Diagnostic Tests for Leprosy

NCT06222372 · Leprosy

RECRUITINGPhase 2

Efficacy and Tolerability of Adjunct Metformin for Multibacillary Leprosy

NCT05243654 · Leprosy, Leprosy, Multibacillary, and more

RECRUITINGNA

Rab 32 Gene Polymorphisms as a Prognostic Factor in Leprosy Patients

NCT06819449 · Leprosy, Mycobacterium Leprae Infection

RECRUITING

TGF β 1 Expression Related Gene Polymorphism

NCT06683690 · Leprosy

COMPLETEDPhase 1

Potential Injection of Human Umbilical Cord Secretome in the Case of Trophic Ulcers (Pre-post Intervention)

NCT05777213 · Trophic Ulcer, Leprosy, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 3, 2015Terms

Trial snapshot

StatusNO_LONGER_AVAILABLE

Phase—

Enrollment—

Start date—

Last updatedApr 3, 2015

Condition

Leprosy

Locations shown

Kaiser Permanente

Irvine, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 3, 2015Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions